These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9078447)

  • 41. In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.
    Pfaller MA; Rhomberg PR; Messer SA; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):259-63. PubMed ID: 25600842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents.
    Pfaller MA; Messer SA; Coffman S
    Antimicrob Agents Chemother; 1997 Apr; 41(4):763-6. PubMed ID: 9087485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods.
    Klepser ME; Ernst EJ; Lewis RE; Ernst ME; Pfaller MA
    Antimicrob Agents Chemother; 1998 May; 42(5):1207-12. PubMed ID: 9593151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods.
    Lewis RE; Klepser ME; Pfaller MA
    Diagn Microbiol Infect Dis; 2000 Feb; 36(2):101-5. PubMed ID: 10705051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents.
    Pfaller MA; Wey S; Gerarden T; Houston A; Wenzel RP
    Diagn Microbiol Infect Dis; 1989; 12(1):1-4. PubMed ID: 2714066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations.
    Stevens DA; Espiritu M; Parmar R
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3407-11. PubMed ID: 15328104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids.
    Tobudic S; Forstner C; Schranz H; Poeppl W; Vychytil A; Burgmann H
    Mycoses; 2013 Nov; 56(6):623-30. PubMed ID: 23551835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
    Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
    J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
    Barchiesi F; Spreghini E; Tomassetti S; Della Vittoria A; Arzeni D; Manso E; Scalise G
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2719-27. PubMed ID: 16870764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.
    Pfaller MA; Messer SA; Mills K; Bolmström A; Jones RN
    J Clin Microbiol; 2001 Dec; 39(12):4387-9. PubMed ID: 11724849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD
    J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical perspectives on echinocandin resistance among Candida species.
    Shields RK; Nguyen MH; Clancy CJ
    Curr Opin Infect Dis; 2015 Dec; 28(6):514-22. PubMed ID: 26524326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Int J Antimicrob Agents; 2017 Sep; 50(3):352-358. PubMed ID: 28689871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the "Dip Effect" Phenomenon in Antifungal Susceptibility Testing of Candida spp. against Echinocandins by Use of Gradient Concentration Strips.
    Siopi M; Tsala M; Siafakas N; Zerva L; Meletiadis J
    J Clin Microbiol; 2015 Nov; 53(11):3654-9. PubMed ID: 26338855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agar disk diffusion susceptibility tests with cilofungin (LY 121019).
    Espinel-Ingroff A; Shadomy S; White S
    J Med Vet Mycol; 1991; 29(2):93-8. PubMed ID: 1880684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods.
    Cantón E; Pemán J; Hervás D; Espinel-Ingroff A
    J Antimicrob Chemother; 2013 Apr; 68(4):864-8. PubMed ID: 23228935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Tomassetti S; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4989-92. PubMed ID: 16304162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.